006620 — DongKoo Bio & Pharma Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapFalling Star

Annual income statement for DongKoo Bio & Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	104,837	125,235	139,216	155,149	194,988
Cost of Revenue
Gross Profit	61,390	70,688	80,618	92,444	117,977
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	99,018	118,773	131,598	147,009	177,946
Operating Profit	5,819	6,463	7,618	8,140	17,042
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,320	18,242	10,300	11,333	7,916
Provision for Income Taxes
Net Income After Taxes	4,569	15,101	9,140	9,327	6,614
Net Income Before Extraordinary Items
Net Income	4,569	15,101	9,140	9,327	6,614
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,569	15,101	9,140	9,327	6,614
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	158	528	325	229	235
Dividends per Share

Discover the metrics influencing DongKoo Bio & Pharma Co's share price